Patents Assigned to CHARLES R. DREW UNIVERSITY OF MEDICINE AND SCIENCE
  • Patent number: 11000065
    Abstract: A system is disclosed that includes a holder having a pressurized chamber and configured to secure an aerosol delivery device at least partially within the pressurized chamber. A test chamber is connected to the holder, the test chamber having an inlet allowing an aerosol from the aerosol delivery device to enter the test chamber.
    Type: Grant
    Filed: August 2, 2017
    Date of Patent: May 11, 2021
    Assignees: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, CHARLES R. DREW UNIVERSITY OF MEDICINE AND SCIENCE
    Inventors: Theodore Friedman, Xuesi Max Shao
  • Patent number: 10919878
    Abstract: Presented herein are MCT4 inhibitors and uses thereof for treating cancer.
    Type: Grant
    Filed: April 25, 2019
    Date of Patent: February 16, 2021
    Assignee: CHARLES R. DREW UNIVERSITY OF MEDICINE AND SCIENCE
    Inventors: Yong Wu, Jay Vadgama, Zhimin Huang, Ke Wu
  • Patent number: 9682093
    Abstract: The invention provides methods, compositions, uses of compositions, assays and kits for modulating brown adipose tissue (BAT) in animals and patients with obesity, insulin resistance and perturbed glucose homeostasis are disclosed. Accordingly, methods, compositions, uses of compositions, and kits are useful for the amelioration of pathological conditions characterized by storage of excess energy, insulin resistance and related metabolic syndromes often associated with obesity.
    Type: Grant
    Filed: April 1, 2013
    Date of Patent: June 20, 2017
    Assignee: Charles R. Drew University of Medicine and Science
    Inventor: Rajan Singh
  • Patent number: 9084814
    Abstract: Provided herein are novel nucleic acid sequences, vectors comprising such nucleic acid sequences, host cells comprising such vectors, and transgenic animals comprising such nucleic acid sequences, and related molecules and methods relating thereto. Such novel nucleic acid sequences, vectors comprising such nucleic acid sequences, host cells comprising such vectors, and transgenic animals comprising such nucleic acid sequences, and related molecules and methods provide conditional overexpression of genes, such as myostatin, and transgenic animals conditionally overexpression genes, such as myostatin.
    Type: Grant
    Filed: July 6, 2012
    Date of Patent: July 21, 2015
    Assignee: CHARLES R. DREW UNIVERSITY OF MEDICINE AND SCIENCE
    Inventor: Suzanne Porszasz-Reisz